'i4MDS' consortium wins prestigious EHA Innovation Grant

Award winners at EHA2024

In a significant development, the International Integrative Innovative Immunology for Myelodysplastic Neoplasms consortium—known as the ‘i4MDS’— has received an esteemed EHA Innovation Grant.

The EHA Innovation Grant is a form of finanical support that's designed to foster novel ideas and projects in the field of hematology. The grant provides crucial funding to initiatives that have the potential to redefine our understanding and treatment of hematological conditions.

The awarding of the grant to the i4MDS consortium is a testament to the groundbreaking work that this group is carrying out. The consortium, with its innovative approach and commitment to advancing the field of hematology, stood out among numerous high-quality applications. The grant will enable it to further its research and potentially bring about significant advancements in the field.

EHA expressed its excitement about the potential impact of the work of the i4MDS consortium and is looking forward to seeing the outcomes of the funded project.

Stay tuned for more updates on the progress of the i4MDS consortium's project and the impact of the EHA Innovation Grant on their work. This is indeed a significant milestone for the consortium and a great boost for research in hematology.

Last Updated on Monday 08 July 2024.